OREM, Utah, March 10, 2025 (GLOBE NEWSWIRE) -- Mity Inc. announces that sales of its new Traversa chair serving the non-emergency medical transport ("NEMT") market have topped $1.6 million since introduction in early 2024.
Mity Inc. is a designer and manufacturer of commercial furniture selling into a variety of markets. Broda Seating is a division of Mity which designs and manufactures various types of wheelchairs (i.e., bariatric, pedal, positioning, and rehabilitation), hygiene chairs, and support accessories (i.e., head/back/arm support and cushions) for the senior living and hospitality end market. In 2024, Broda introduced the new Traversa line specifically for the NEMT market.
The Traversa chair is the NEMT industry’s first alternative to traditional stretchers and gurneys. The Traversa can recline up to 90 degrees and tilt up to 20 degrees. Unlike stretchers and gurneys that require multiple operators, the Traversa wheelchair only requires one operator, resulting in significant labor cost savings for the NEMT service provider. The Traversa chair has been one of Broda’s most successful and popular new product launches.
Broda Seating will be showing the new Traversa chair at the Vancouver Rehab Equipment Expo (REE) in Vancouver, British Columbia, on March 4.
About Mity Inc.:
Mity Inc. is a designer and manufacturer of commercial furniture for a range of markets, including hospitality, convention center, restaurants, senior living, and religious institutions. Mity sells via its four brands: Mity-Lite, Holsag, Bertolini, and Broda. Mity is based in Orem, Utah, and also has operations in Lindsay, Ontario and Kitchener, Ontario.
Mity Inc. is a portfolio company of Prospect Capital Corporation (NASDAQ: PSEC), a publicly traded business development company with $7.2 billion of total assets as of December 31, 2024.
For further information, contact:
Kevin McCoy
Kevin.McCoy@mityinc.com
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/e149c090-efef-49c4-9971-b407c7ac393a
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。